Sone-217 -

| Phase | Status | Key Milestones | |-------|--------|----------------| | IND‑enabling | Completed (2023) | GLP toxicology, IND‑ready CMC, pre‑IND meeting with FDA (July 2023). | | Phase 1 (Healthy volunteers) | Completed (Sept 2024) | Single‑ascending dose (SAD) up to 200 mg; multiple‑ascending dose (MAD) up to 100 mg bid for 14 days. No serious AEs; PK linear; mild transient GI upset in 2 % of subjects. | | Phase 1b (Gout flare‑prevention) | Ongoing (expected read‑out Q1 2025) | Primary: reduction in flare frequency over 12 weeks; secondary: serum IL‑1β, safety. | | Phase 2a (Type‑2 Diabetes) | Initiated (Jan 2025) | 150 participants; 12‑month double‑blind; primary: change in HbA1c; secondary: inflammatory biomarkers, liver fat (MRI‑PDFF). | | Phase 2b (Alzheimer’s disease – early‑MCI) | Planned (2026) | Adaptive design; 300 participants; primary: ADAS‑Cog13 change at 18 months; biomarker sub‑study (CSF IL‑1β, PET‑Tau). | | Regulatory Path | Seeking Fast Track (FDA) & Orphan Drug designation for familial Mediterranean fever (FMF) (application filed Apr 2025). |

Interpretation: The company has opted for a parallel‑track strategy, leveraging the same mechanism in both acute (gout) and chronic (diabetes, neuro‑degeneration) settings. Early safety data are encouraging, and the PK profile is compatible with once‑daily dosing—critical for chronic indications.

In scientific research, technological development, and even in fictional narratives, designations like SONE-217 serve as markers of progress. They denote projects, experiments, or products that have reached a significant milestone, warranting recognition and further attention. These codes often protect the intellectual property or the conceptual integrity of the work until it is ready to be unveiled to the world.

The designation SONE-217 represents more than just a video title; it is a product of a highly organized media industry. Through the standardized coding system, strict adherence to domestic censorship laws, and high production standards set by labels like S1, the Japanese AV industry maintains a distinct structure. Understanding these codes provides insight into how this sector of the entertainment industry manages its vast catalog of content. SONE-217

SONE-217 is a 120-minute Japanese adult video released on August 19, 2021, by the S1 No. 1 Style label featuring actress Nanami Kodama. Directed by Tatsuo Sone, the production is categorized within the "office lady" genre. Detailed production credits and distribution history for this release can be found in specialized databases like the Japanese Adult Video Database. 

The code SONE-217 typically refers to a production from the Japanese adult entertainment industry, specifically under the S-ONE (or S1) studio label. Review of SONE-217

Production Quality: As a release from S-ONE, one of Japan's premium "No. 1" studios, the technical production is generally high. This includes professional lighting, clear cinematography, and high-definition resolution typical of the label's "Number One" branding. | Phase | Status | Key Milestones |

Theme & Narrative: S-ONE titles often feature specific "idol" performers or high-concept scenarios. SONE-217 follows the studio's standard format of focusing on a lead actress in a highly produced, narrative-driven setting.

Performer Focus: This specific entry is known for its focus on a singular lead performer, a common strategy for the SONE series which aims to build the "exclusive" status of its stars. Technical Details Studio: S1 No. 1 Style (S-ONE).

Label Code: The "SONE" prefix is the unique identifier used by this studio for many of its digital and physical releases. Interpretation: The company has opted for a parallel‑track

Content Warning: This is adult-oriented content intended for mature audiences only. 217. Sone 035

In the Japanese AV industry, the alphanumeric code (e.g., SONE-217) functions similarly to an ISBN for books or a SKU for retail products.

This coding system allows consumers and retailers to track specific titles efficiently, distinguishing between different works featuring the same performer or different release dates. SONE-217 was released in early 2024, adhering to the studio's monthly release cycle.

The prefix "SONE" identifies the production studio as S1 No. 1 Style. S1 is a prominent label known for high production values and for casting "AV Idols"—performers who often achieve celebrity status within the genre. The studio is recognized for its distinct visual aesthetic and marketing approach, often focusing on performers with mainstream appeal.

The "SONE" series is the primary cataloging series used by S1 for their major releases. When a title is assigned a number in this series (such as 217), it signifies a specific entry in their chronological release schedule.